| Literature DB >> 29723967 |
Guanquan Lin1,2, Huayao Chen3,4, Hongjun Zhou5,6, Xinhua Zhou7,8, Hua Xu9,10.
Abstract
Using butyl methacrylate (Entities:
Keywords: anti-bacterial effect; microspheres; sustained release; tea tree oil
Year: 2018 PMID: 29723967 PMCID: PMC5978087 DOI: 10.3390/ma11050710
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1FTIR spectra of TTO, P(St-BMA) microspheres, and TTO microspheres.
FTIR spectra absorption peaks of TTO, P(St-BMA) microspheres, and TTO microspheres.
| Functional Group | Wavelength (cm−1) | ||
|---|---|---|---|
| TTO | P(St-BMA) Microspheres | TTO Microspheres | |
| O–H stretching vibration | 3478. | - | 3447 |
| C–H (benzene ring) stretching vibration | - | 2926, 1450 | 2926, 1452 |
| C–H (C=C) stretching vibration | 2965 | - | 2965 |
| carbonyl stretching vibration | - | 1729 | 1729 |
| C–C (benzene ring) stretching vibration | - | 1600 | 1600 |
| C–O (ester) stretching vibration | 1166 | 1174 | 1174 |
| C–O (tertiary alcohol in terpenes) stretching vibration | 1127 | - | 1127 |
| C=C stretching vibration | 902 | - | 910 |
| C–H (benzene ring) plane bending vibration | - | 763, 688 | 763, 689 |
Figure 2Surface topography of P(St-BMA) microspheres (a) and TTO microspheres (b).
Figure 3(a) TGA curves of TTO, P(St-BMA) microspheres, and TTO microspheres, and (b) TGA and DTG curves of the TTO microspheres.
Figure 4(a) Oil absorption characteristics of the P(St-BMA) microspheres at different monomer ratios and (b) oil absorption characteristics of the P(St-BMA) microspheres at different dosages of the DVB crosslinking agent.
Figure 5(a) Sustained release properties of the TTO microspheres at different monomer ratios and (b) sustained release properties of TTO microspheres at various dosages of the DVB crosslinking agent.
Fitting results for release curves at various monomer ratios.
| Kinetic Model | Zero-Order | First-Order | Higuchi | Korsmeyer-Peppas | |
|---|---|---|---|---|---|
| Sample |
|
| |||
| mSt:mBMA = 2:8 | 0.7599 | 0.8863 | 0.9288 | 0.9733 | 0.3418 |
| mSt:mBMA = 4:6 | 0.7365 | 0.8963 | 0.9221 | 0.9759 | 0.4446 |
| mSt:mBMA = 6:4 | 0.7094 | 0.8487 | 0.9018 | 0.9718 | 0.4191 |
| mSt:mBMA = 8:2 | 0.8049 | 0.8687 | 0.9567 | 0.9937 | 0.3275 |
| mSt:mBMA = 10:0 | 0.8782 | 0.9383 | 0.9844 | 0.9886 | 0.4005 |
Figure 6(a) Inhibition zones of TTO at various dosages 20 μL (a), 30 μL (a), 40 μL (a), and 50 μL (a) for 24 h; (b) inhibition zones of TTO microspheres at various dosages 20 μL (b), 30 μL (b), 40 μL (b), and 50 μL (b) for 24 h; and (c) anti-bacterial rate of TTO and TTO microspheres at various dosages.
Figure 7(a) Inhibition zones of TTO at various release times 0 h (a), 12 h (a), 24 h (a), and 36 h (a); (b) inhibition zones of TTO microspheres at various release times 0 h (b), 12 h (b), 24 h (b), and 36 h (b); and (c) anti-bacterial rate of TTO and TTO microspheres at various release times.
Figure 8Schematic representation for the synthesis of TTO microspheres.